Abstract:The exponential increase in the prevalence of prediabetes has become a global concern due to the comorbidities and mortality rates that are positively associated with it. The incidence of prediabetes is directly proportional to the prevalence of comorbidities with risk factors such as insulin resistance, adiposity, lipotoxicity, obesity and the alteration of the renin-angiotensin-aldosterone system. Hence, the current study systematically reviewed and performed a meta-analysis of these risk factors, their clinical indicators and the RAAS components. This systematic review was developed in compliance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-2020) standards. This was accomplished by searching clinical MeSH categories in MEDLINE with full texts, EMBASE, Web of Science, PubMed, Cochrane Library, Academic Search Complete, ICTRP and ClinicalTrial.gov. Reviewers examined all the findings and selected the studies that satisfied the inclusion criteria. The Downs and Black Checklist was used to assess for bias, followed by a Review Manager v5. A Forrest plot was used for the meta-analysis and sensitivity analysis. The protocol for this review was registered with PROSPERO CRD42022320252. The clinical studies ( n = 2) comprised 1065 patients with prediabetes and 1103 normal controls. The RAAS measurements were completed in the adipose tissue. The RAAS components, renin and aldosterone were higher in the prediabetic (PD) compared to the control [mean difference (MD) = 0.16, 95% CI 0.16 (−0.13, 0.45), p = 0.25]. Furthermore, the PD group demonstrated higher triglycerides mean difference [MD = 7.84, 95% CI 7.84 (−9.84, 25.51), p = 0.38] and increased BMI [MD = 0.13, 95% CI 0.13 (−0.74, 0.99), p = 0.77] compared to the control. The overall quality of the studies was fair with a median score and range of 17 (16–18). The current study highlights the relationship between increased BMI, RAAS and insulin resistance which is a predictor of prediabetes. The renin is slightly higher in the prediabetes group without any statistical significance, aldosterone is rather negatively associated with prediabetes which may be attributed to the use of anti-hypertensive treatment.

Assessment of Possible Role of Renin Angiotensin Aldosterone System in Obesity: Review Article

Role of Renin-Angiotensin-aldosterone System in Adipose Tissue Dysfunction.

Implications for Obesity Hypertension

Classical and Alternative Pathways of the Renin–Angiotensin–Aldosterone System in Regulating Blood Pressure in Hypertension and Obese Adolescents

The local renin-angiotensin system in adipose tissue and its relationship with metabolic syndrome

Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity

Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases

The relationship between adipose tissue RAAS activity and the risk factors of prediabetes: a systematic review and meta-analysis

Relationship between RAS and Obesity-Associated Hypertension

biochemical study of angiotensin II, electrolytes and vitamin D in obese patients

The renin angiotensin aldosterone system and insulin resistance in humans

The Role of the Autonomic Nervous System in the Pathophysiology of Obesity

Improving obesity and blood pressure

Beyond blood pressure, fluid and electrolyte homeostasis – Role of the renin angiotensin aldosterone system in the interplay between metabolic diseases and breast cancer

Rising Prevalence of Obesity and Primary Hyperaldosteronism: Co-incidence or Connected Circumstances Leading to Hypertension? A Narrative Review

The mineralocorticoid system, cardiometabolic health and its interplay with adipose tissue

The renin-angiotensin-aldosterone system (RAAS) - physiology and molecular mechanisms of functioning

Leptin-Induced Sympathetic Nerve Activation: Signaling Mechanisms and Cardiovascular Consequences in Obesity

Obesity-related hypertension and chronic kidney disease: from evaluation to management

Metabolic Rate Regulation by the Renin–angiotensin System: Brain Vs. Body

Factors Responsible for Obesity-Related Hypertension